This inventor holds 7 USPTO granted patents and 2 published patent applications. Top assignees: University of California, Invvax, Inc.. Active years: 2012-2025.
Location History:
- Los Angeles, CA (US) (2021 - 2023)
- Pacific Palisades, CA (US) (2012 - 2024)
Company Filing History:
6 out of 15,977 
3 out of 3 Years Active: 2012-2025
Title: Ren Sun: Innovator in Influenza Vaccine Development
Introduction
Ren Sun is a prominent inventor based in Pacific Palisades, CA (US). He has made significant contributions to the field of vaccine development, particularly in influenza vaccines. With a total of 7 patents to his name, Sun's work has advanced the understanding and creation of effective vaccines.
Latest Patents
One of Ren Sun's latest patents focuses on influenza vaccines. This patent includes compositions related to various types of vaccines, such as peptide-based, nucleic acid-based, recombinant virus-based, antibody-based, and virus-based vaccines. Additionally, it outlines methods for identifying epitopes for these vaccines, as well as procedures for producing, formulating, and administering them. Another notable patent involves the genome-wide identification of immune evasion functions in a virus. This protocol allows for the genetic engineering of an attenuated pathogen, such as the influenza virus, which can grow in cells without interferons while exhibiting suppressed growth in interferon-rich environments. The resulting attenuated pathogen is designed to elicit a strong immunologic response and can be utilized in live attenuated vaccines.
Career Highlights
Throughout his career, Ren Sun has worked with esteemed institutions, including the University of California and Invvax, Inc. His innovative research has positioned him as a leader in the field of vaccine technology.
Collaborations
Ren Sun has collaborated with notable colleagues, including Nicholas C Wu and Arthur Young. These partnerships have further enriched his research and contributions to vaccine development.
Conclusion
Ren Sun's work in the field of influenza vaccines exemplifies his dedication to advancing medical science. His innovative patents and collaborations highlight his significant impact on vaccine technology.